PharmTech Drug Digest 11.20
News|Articles|January 28, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-02-03-2016
  • Volume 12
  • Issue 2

Onyx Scientific Announces Facility Expansion

Planned expansion at Onyx Scientific add laboratories, GMP suites, and storage space.

Onyx Scientific, a UK-based contract research organization and and small-scale API manufacturer, has announced an investment in an additional site located adjacent to its existing facility in North-East England to increase its laboratory facilities, GMP suites, and storage of GMP materials. In addition, the company has recruited several more chemists to support clients’ pre-clinical, development, and early-stage API manufacturing projects.

In 2015, the company grew its GMP space following an increase in demand for its small-scale API manufacturing services, according to a Jan. 28, 2016 press statement.

Established in 2000, the company provides clients with the production of API in up to 50 L–100 L equipment under current GMP regulations, and also offers earlier stage custom synthesis, lead optimization, and analytical services.

Source: Onyx Scientific

 


Related to this article

Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.
Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.